These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Ikeda M; Ikeda A; Longan LC; Longnecker R Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340 [TBL] [Abstract][Full Text] [Related]
3. Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling. Ikeda A; Caldwell RG; Longnecker R; Ikeda M J Virol; 2003 May; 77(9):5529-34. PubMed ID: 12692257 [TBL] [Abstract][Full Text] [Related]
4. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. Ikeda M; Ikeda A; Longnecker R J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981 [TBL] [Abstract][Full Text] [Related]
5. The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling. Ikeda M; Longnecker R Virology; 2009 Mar; 385(1):183-91. PubMed ID: 19081591 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation. Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694 [TBL] [Abstract][Full Text] [Related]
7. Identification of the WW domain-interaction sites in the unstructured N-terminal domain of EBV LMP 2A. Seo MD; Park SJ; Kim HJ; Lee BJ FEBS Lett; 2007 Jan; 581(1):65-70. PubMed ID: 17174309 [TBL] [Abstract][Full Text] [Related]
9. The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor. Ingham RJ; Raaijmakers J; Lim CS; Mbamalu G; Gish G; Chen F; Matskova L; Ernberg I; Winberg G; Pawson T J Biol Chem; 2005 Oct; 280(40):34133-42. PubMed ID: 16087662 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease. Cooper L; Longnecker R Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506 [TBL] [Abstract][Full Text] [Related]
12. The LMP2A protein of Epstein-Barr virus regulates phosphorylation of ITSN1 and Shb adaptors by tyrosine kinases. Dergai O; Dergai M; Skrypkina I; Matskova L; Tsyba L; Gudkova D; Rynditch A Cell Signal; 2013 Jan; 25(1):33-40. PubMed ID: 22975684 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn. Rovedo M; Longnecker R J Virol; 2008 Sep; 82(17):8520-8. PubMed ID: 18579586 [TBL] [Abstract][Full Text] [Related]
14. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Fruehling S; Longnecker R Virology; 1997 Sep; 235(2):241-51. PubMed ID: 9281504 [TBL] [Abstract][Full Text] [Related]
15. Latent Membrane Protein 2 (LMP2). Cen O; Longnecker R Curr Top Microbiol Immunol; 2015; 391():151-80. PubMed ID: 26428374 [TBL] [Abstract][Full Text] [Related]
16. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein. Matskova LV; Helmstetter C; Ingham RJ; Gish G; Lindholm CK; Ernberg I; Pawson T; Winberg G Oncogene; 2007 Jul; 26(34):4908-17. PubMed ID: 17311000 [TBL] [Abstract][Full Text] [Related]
17. N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein. Harvey KF; Shearwin-Whyatt LM; Fotia A; Parton RG; Kumar S J Biol Chem; 2002 Mar; 277(11):9307-17. PubMed ID: 11748237 [TBL] [Abstract][Full Text] [Related]